@FinchTH I like the variant with a single 5x20x20 MERV 16 filter. Good performance and can't really get any simpler to assemble (can use tape or velcro instead of the rubber bands, but the rubber bands make filter replacement very easy!)
https://twitter.com/Read4Ks/st...

@FinchTH 我喜欢带有单个 5x20x20 MERV 16 过滤器的变体。性能好，组装起来再简单不过了（可以使用胶带或魔术贴代替橡皮筋，但橡皮筋使更换过滤器非常容易！）
https://twitter.com/Read4Ks/st...

@GainOfDystopia @Michael34301004 @FinchTH @CRBoxKits @sri_srikrishna 3M also has slightly better MPR 2200 which still rate as MERV 13. Probably not a significant difference, but sometimes one or the other may be out of stock or discounted. Likewise MPR 2400/2800 both MERV 14.

@GainOfDystopia @Michael34301004 @FinchTH @CRBoxKits @sri_srikrishna 3M 的 MPR 2200 也稍好一些，仍被评为 MERV 13。可能没有显着差异，但有时其中一个或另一个可能缺货或打折。同样 MPR 2400/2800 和 MERV 14。

@BrianCCastrucci @craigsastic @MonicaGandhi9 Even if there were some evidence of a possible effect, they wouldn't know the cause in an INDIVIDUAL case. That's misinformation.

@BrianCCastrucci @craigsastic @MonicaGandhi9 即使有一些证据表明可能产生影响，他们也不知道个别案件的原因。那是错误的信息。

@_mattie @jfeldman_epi Any health insurance, any medicare, or medicaid (medicaid has more restrictions but can usually still get some tests). That's 90% of the population.

@_mattie @jfeldman_epi 任何健康保险、任何医疗保险或医疗补助（医疗补助有更多限制，但通常仍然可以进行一些测试）。那是90%的人口。

@GYamey And actual concerted high-impact and high-capability booster campaign in the US would be the first. But I doubt it will happen. "Booster campaign" is US-speak for "go get one if you want one".

@GYamey 在美国实际协调一致的高影响力和高能力助推器活动将是第一个。但我怀疑它会发生。 “助推器活动”是美国所说的“如果你想要一个就去买一个”。

@whstancil That's conflated by kitchen table gas prices.

@whstancil 这与厨房餐桌的汽油价格混为一谈。

@jsherman256 Huge difference I think, even for a modest breeze.

@jsherman256 我认为差异很大，即使是微风。

@dh112358 @DrLeanaWen @PostOpinions My mistake I thought she mentioned it in an interview but now I'm wondering if it might have been someone else. I'll delete it.

@dh112358 @DrLeanaWen @PostOpinions 我的错误我以为她在采访中提到了它，但现在我想知道它是否可能是其他人。我会删除它。

@__philipn__ @wsbgnl I probably wasn't clear in that I wasn't just referring to docs. It likely extends to other issues of policy. Access in exchange for getting the right message out.

@__philipn__ @wsbgnl 我可能不清楚，因为我不只是指文档。它可能会延伸到其他政策问题。访问以换取正确的消息。

@__philipn__ @wsbgnl Probably because a huge number of others writers are doing the same thing. The 'access' game goes deep.

@__philipn__ @wsbgnl 可能是因为大量其他作家也在做同样的事情。 “访问”游戏深入人心。

@dh112358 @DrLeanaWen @PostOpinions What she doesn't mention is they got covid in January and decided that immunity was enough. That's why.

@dh112358 @DrLeanaWen @PostOpinions 她没有提到的是他们在一月份感染了新冠病毒并决定免疫就足够了。这就是为什么。

@__philipn__ @wsbgnl Every time she (or her writing) appears in public.
Also mention that it is a conference call where the White House tells the 'experts' "here is what we want all of you to be saying" because "When a public health expert says it, it carries more weight".

@__philipn__ @wsbgnl 每次她（或她的作品）出现在公众面前。
还提到这是一次电话会议，白宫告诉“专家”“这是我们希望你们所有人说的话”，因为“当公共卫生专家这么说时，它会更有分量”。

@SteveAHorn I can't believe Novavax wouldn't be happy to be acquired if they had a hit product and could command a good price. Not being a year to 18 months late to the market would have helped a lot. This was a winner-take-most race.

@SteveAHorn 我不敢相信如果 Novavax 有一款热门产品并且可以卖个好价钱，他们会不高兴被收购。不迟到市场一年到 18 个月会有很大帮助。这是一场赢者通吃的比赛。

@SteveAHorn Pfizer was anything but a one trick pony. It had $40 billion in revenue in 2019. Maybe you meant Moderna?
J&J got utterly shafted and I guess gave up, even as the similar Oxford/AX continues on and is working on a nasal version.

@SteveAHorn Pfizer 绝不是一招一式的小马。它在 2019 年的收入为 400 亿美元。也许你指的是 Moderna？
Ĵ

@SteveAHorn Where's Moderna, and especially where was Moderna when they had Novavax-level revenue?
To a large extent it was a race for winner-take-most, which Moderna won in 2020, given them the resources to move quickly. Novavax just submitted a booster application last week, a year late.

@SteveAHorn Moderna 在哪里，尤其是当他们有 Novavax 级别的收入时，Moderna 在哪里？
在很大程度上，这是一场赢者通吃的竞赛，Moderna 在 2020 年赢得了比赛，为他们提供了快速行动的资源。 Novavax 上周刚刚提交了一份助推器申请，比这晚了一年。

@Jeffrey60074 @DrEricDing @bellichka @mildanalyst @farid__jalali Found in air samples:
https://www.medrxiv.org/conten...

@Jeffrey60074 @DrEricDing @bellichka @mildanalyst @farid__jalali 在空气样本中发现：
https://www.medrxiv.org/conten...

@SteveAHorn Right, Moderna has definitely been treated better than J&J. This isn't a 'big pharma' thing even as one can be highly critical of how FDA and CDC have handled it all.

@SteveAHorn 对，Moderna 的待遇肯定比 J 好

@SteveAHorn Moderna isn't any more 'big pharma' than Novavax, or at least wasn't before they started selling Covid shots.

@SteveAHorn Moderna 并不比 Novavax 更“大制药公司”，或者至少在他们开始销售 Covid 疫苗之前不是。

@__philipn__ @billybinion @nberlat I'm not sure but I think NY doesn't report later rounds until the first round is resolved. There might be some statistical data on 2nd+ choices but it's less prominent than 1st choice in-progress counts.

@__philipn__ @billybinion @nberlat 我不确定，但我认为纽约在第一轮解决之前不会报告后续轮次。可能有一些关于第二选择的统计数据，但它不如第一选择进行中计数突出。

@__philipn__ @billybinion @nberlat Blue check up there is appealing to outrage and delegitimization of an elected candidate by claiming runoffs with large fields whether instant or not doesn't represent the will of the people. Looks like nonsense to me.

@__philipn__ @billybinion @nberlat Blue 检查那里通过声称具有大面积的决选（无论是否即时）不代表人民的意愿，呼吁对民选候选人的愤怒和非法化。在我看来是胡说八道。